| 901 | JOHNSON, KATHLEEN CASEYDURHAM, NC · 27709 | REGIONAL ACCOUNT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 902 | HARTMAN, STACI LAWSONDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 903 | O'NEILL, KELLY ANNMARIETTA, PA · 17547 | DISTRIBUTION · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 904 | STEIRER, JOSEPH PDURHAM, NC · 27709 | RX SALES VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 905 | HOCH, JEFFREY SCOTTDURHAM, NC · 27709 | FVP, VACCINES SALES LEAD · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 906 | FANUTTI, JULIE ANNPHILADELPHIA, PA · 19112 | SALES AND/OR MARKETING TRAINING (ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 907 | NIJINSKY, SONYA ALEXANDRA MOIRAPHILADELPHIA, PA · 19112 | INTERNAL QUALITY AUDIT · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 908 | SHELBY, URSULA DDURHAM, NC · 27709 | ADULT IMMUNIZATION SPECIALIST · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 909 | GALLOWAY, BIJALDURHAM, NC · 27701 | SENIOR GLOBAL MARKETING DIRECTOR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 910 | BULCHANDANI, ANILDURHAM, NC · 27709 | PRICING/REIMBURSEMENT - ANIL BULCHANDA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-21 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 911 | HALL, DENISE C.PHILADELPHIA, PA · 19112 | E-DISCOVERY PROCESS PARTNER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 912 | LOUGHLIN, CATHERINEDURHAM, NC · 27701 | VICE PRESIDENT, US SPECIALTY AND ONCOL · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 913 | GROSS, APRIL DDURHAM, NC · 27709 | SR SALES SPEC, PHARMA · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 914 | FURUYA, CHRIS A.DURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 915 | JOHNSON, KATHLEEN CASEYDURHAM, NC · 27709 | REGIONAL ACCOUNT EXECUTIVE · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 916 | GALLOWAY, BIJALDURHAM, NC · 27701 | SENIOR GLOBAL MARKETING DIRECTOR · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 917 | HARTMAN, STACI LAWSONDURHAM, NC · 27709 | RX ACCOUNT MANAGEMENT RESP BIOLOGICS · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 918 | MONNIER, MICHELLE MPHILADELPHIA, PA · 19112 | SENIOR DIRECTOR, PUBLIC SEGMENT MARKET · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 919 | GREENGROVE, KATHRYN ANNEDURHAM, NC · 27701 | SR. DIRECTOR US PHARMA COMMERCIAL OPER · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |
| 920 | STEIRER, JOSEPH PDURHAM, NC · 27709 | RX SALES VACCINES · GLAXOSMITHKLINE LLC | GLAXOSMITHKLINE LLC PAC (GSK PAC)C00199703 | 2026-09-04 | $15 | Primary (P) | Filing 2018012FEC filing ↗ |